目的 探讨血栓性微血管病(thrombotic microangiopathy, TMA)的临床特点和治疗,以加深对本病的认识.方法 回顾分析12例TMA患者的临床表现、实验室检查、治疗及预后.结果 12例患者主要临床表现为微血管性溶血性贫血(12/12),血小板减少(12/12),肾脏受损(12/12),神经精神症状(6/12),发热(7/12).8例进行了血浆置换(8/12),1例死于合并症(1/8),7例好转出院(7/8);余4例血浆输注(4/12),1例死于本病(1/4),3例好转出院(3/4).结论 TMA临床表现多样,病因复杂,起病急,病情危重,预后差;提高认识,及早诊治可以改善预后,降低死亡率.Objective To explore clinical characteristics and treatment of the thrombotic microangiopathy(TMA), to improve the recognition of TMA.Methods The clinical manifestations, laboratory examinations, therapeutic methods and prognosis of 12 TMA patients were analyzed retrospectively.Results The clinical manifestations were characterized by microangiopathic hemolytic anemia(12/12), thrombocytopenia(12/12), renal lesion(12/12), fever(7/12), and ...
Background Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and m...
Background Cancer-associated thrombotic microangiopathy (TMA) is a rare disease, with a poor prognos...
International audienceContext - The management of systemic auto-immune diseases (SAID) -associated t...
血栓性微血管病(thrombotic microangiopathy,TMA)是一组急性临床病理综合征.经典的血栓性微血管病主要指溶血尿毒综合征(hemolytic uremic syndrome,H...
目的 探讨恶性高血压病所致血栓性微血管病(TMA)的临床特点和治疗效果.方法 回顾性分析15例恶性高血压病所致TMA患者的临床表现、实验室检查、治疗和预后.结果 15例患者中原发性高血压病3例(3∕1...
Background : Thrombotic Microangiopathy (TMA) is defined as a lesion comprising vessel wall thickeni...
BACKGROUND AND OBJECTIVES: Thrombotic microangiopathies constitute a diagnostic and therapeutic chal...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
血栓性微血管病(thrombotic microangiopathy,TMA)是一组急性临床病理综合征,其主要特征是微血管病性溶血性贫血、血小板下降以及微血管内血栓形成[1].肾脏受累时多引起急性肾衰...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
Cilj istraživanja: Cilj ovog rada bio je utvrditi pojavnost trombotične mikroangiopatije u djece lij...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
OBJECTIVE To describe the clinical characteristics, treatment, and outcomes of a multinational co...
Background Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and m...
Background Cancer-associated thrombotic microangiopathy (TMA) is a rare disease, with a poor prognos...
International audienceContext - The management of systemic auto-immune diseases (SAID) -associated t...
血栓性微血管病(thrombotic microangiopathy,TMA)是一组急性临床病理综合征.经典的血栓性微血管病主要指溶血尿毒综合征(hemolytic uremic syndrome,H...
目的 探讨恶性高血压病所致血栓性微血管病(TMA)的临床特点和治疗效果.方法 回顾性分析15例恶性高血压病所致TMA患者的临床表现、实验室检查、治疗和预后.结果 15例患者中原发性高血压病3例(3∕1...
Background : Thrombotic Microangiopathy (TMA) is defined as a lesion comprising vessel wall thickeni...
BACKGROUND AND OBJECTIVES: Thrombotic microangiopathies constitute a diagnostic and therapeutic chal...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
血栓性微血管病(thrombotic microangiopathy,TMA)是一组急性临床病理综合征,其主要特征是微血管病性溶血性贫血、血小板下降以及微血管内血栓形成[1].肾脏受累时多引起急性肾衰...
Thrombotic microangiopathies (TMAs) are rare, but life-threatening disorders characterized by microa...
The term thrombotic microangiopathy (TMA) has been used to describe multiple disease entities charac...
Cilj istraživanja: Cilj ovog rada bio je utvrditi pojavnost trombotične mikroangiopatije u djece lij...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
Objective. The current study aimed to investigate the spectrum of etiologies and associated disorder...
OBJECTIVE To describe the clinical characteristics, treatment, and outcomes of a multinational co...
Background Thrombotic microangiopathy (TMA) with non-deficient ADAMTS-13 (a disintegrin-like and m...
Background Cancer-associated thrombotic microangiopathy (TMA) is a rare disease, with a poor prognos...
International audienceContext - The management of systemic auto-immune diseases (SAID) -associated t...